Analytics Insight9d
Exploring Novel Therapies in Ulcerative Colitis: Insights from Phase II Clinical Trials
Ulcerative colitis (UC) is one of the most severe chronic diseases, causing relentless gastrointestinal pain and ...
The Manila Times7d
ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China
Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced the successful completion of the Phase III clinical study ...